Javascript must be enabled to continue!
Survival nomograms for stage III colorectal cancer
View through CrossRef
Abstract
The postoperative survival of patients with stage III colorectal cancer (CRC) various obviously. We sought to develop novel nomograms for predicting the survival of these patients after radical surgery and postoperative chemotherapy.
A total of 620 consecutive patients with stage III CRC who underwent curative resection and postoperative chemotherapy between January 2009 and December 2015 were retrospectively collected and randomly allocated to the training (n = 372) or validation cohort (n = 248). Clinicopathological factors were collected and analyzed. On the basis of data from 372 patients in the training set, predictive factors for overall survival (OS) and disease-free survival (DFS) were identified using multivariate Cox regression and used to construct nomograms. The predictive performance of the nomograms was assessed by concordance index (C-index) and calibration plots. An external cohort of 248 patients was used to validate the nomograms. Furthermore, nomogram performance was compared with the performance of T and N stage stratification.
Tumor differentiation grade, lymph node metastasis ratio, intravascular emboli (IVE), preoperative serum carcinoembryonic antigen (CEA) level, albumin to globulin ratio (AGR), T stage and N stage were significant prognostic factors for OS on multivariate analysis; whereas, Tumor differentiation grade, lymph node metastasis ratio, IVE, AGR and N stage were significant for DFS. Nomograms to predict 3- and 5-year OS and DFS were established that performed well (C-indexes of 0.734 [95% CI, 0.691–0.779] for OS and 0.699 [95% CI, 0.657–0.740] for DFS prediction), and nomogram accuracy was confirmed in the validation cohort. Furthermore, model comparison proved that the nomograms were superior to risk stratification by T and N stage for stage III CRC.
We propose 2 practical nomograms for stage III CRC patients that provide more accurate prognostic predictions and should be helpful for guiding individualized treatment and postoperative surveillance.
Ovid Technologies (Wolters Kluwer Health)
Title: Survival nomograms for stage III colorectal cancer
Description:
Abstract
The postoperative survival of patients with stage III colorectal cancer (CRC) various obviously.
We sought to develop novel nomograms for predicting the survival of these patients after radical surgery and postoperative chemotherapy.
A total of 620 consecutive patients with stage III CRC who underwent curative resection and postoperative chemotherapy between January 2009 and December 2015 were retrospectively collected and randomly allocated to the training (n = 372) or validation cohort (n = 248).
Clinicopathological factors were collected and analyzed.
On the basis of data from 372 patients in the training set, predictive factors for overall survival (OS) and disease-free survival (DFS) were identified using multivariate Cox regression and used to construct nomograms.
The predictive performance of the nomograms was assessed by concordance index (C-index) and calibration plots.
An external cohort of 248 patients was used to validate the nomograms.
Furthermore, nomogram performance was compared with the performance of T and N stage stratification.
Tumor differentiation grade, lymph node metastasis ratio, intravascular emboli (IVE), preoperative serum carcinoembryonic antigen (CEA) level, albumin to globulin ratio (AGR), T stage and N stage were significant prognostic factors for OS on multivariate analysis; whereas, Tumor differentiation grade, lymph node metastasis ratio, IVE, AGR and N stage were significant for DFS.
Nomograms to predict 3- and 5-year OS and DFS were established that performed well (C-indexes of 0.
734 [95% CI, 0.
691–0.
779] for OS and 0.
699 [95% CI, 0.
657–0.
740] for DFS prediction), and nomogram accuracy was confirmed in the validation cohort.
Furthermore, model comparison proved that the nomograms were superior to risk stratification by T and N stage for stage III CRC.
We propose 2 practical nomograms for stage III CRC patients that provide more accurate prognostic predictions and should be helpful for guiding individualized treatment and postoperative surveillance.
Related Results
Abstract A13: Applied the proteomics characteristics to detect the inherited colorectal adenomas
Abstract A13: Applied the proteomics characteristics to detect the inherited colorectal adenomas
Abstract
Introduction: Current study found that about one-third of the incidence of colorectal cancer have genetic related. Hereditary nonpolyposis colorectal cancer...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Abstract 5777: Functional role of PLK1 in colorectal cancer progression and its potential to chemoresistance
Abstract 5777: Functional role of PLK1 in colorectal cancer progression and its potential to chemoresistance
Abstract
OBJECTIVE:
Colorectal cancer is a cancer with high prevalence and mortality rates worldwide, treated with surger...
The prevention of colorectal cancer
The prevention of colorectal cancer
Colorectal cancer is a leading cause of cancer mortality in the industrialized world. Survival remains poor because most cases are diagnosed at an advanced stage. It is a preventab...
Abstract 1557: Overexpressions of ALEX1 gene play a negative role in human colorectal tumorigenesis
Abstract 1557: Overexpressions of ALEX1 gene play a negative role in human colorectal tumorigenesis
Abstract
Background: Arm protein lost in epithelial cancers, on chromosome X (ALEX) is a novel subgroup within the armadillo family which has several ARM repeat doma...
Abstract A99: Early colorectal cancer in an inner city hospital: Is the current guideline detecting preneoplastic lesions early enough?
Abstract A99: Early colorectal cancer in an inner city hospital: Is the current guideline detecting preneoplastic lesions early enough?
Abstract
Background: Early colorectal cancer refers to cancer diagnosed prior to the screening age of 50 years old or before the age of 55. Each patient's risk for t...
Diagnostic nomogram for distant metastasis in newly diagnosed colorectal cancer based on clinical features
Diagnostic nomogram for distant metastasis in newly diagnosed colorectal cancer based on clinical features
Abstract
Background
Colorectal cancer is one of the most common primary malignancies and the third most common cause of cancer death in both men and women in the United St...
A Novel Nutrition-Based Nomogram to Predict Prognosis After Curative Resection of Gastric Cancer
A Novel Nutrition-Based Nomogram to Predict Prognosis After Curative Resection of Gastric Cancer
Objective: We sought to investigate the prognostic significance of body composition and weight change during the first 6 months of adjuvant chemotherapy after R0 resection and deve...

